Research Summary
Research Summary
01/09/2015
Miranda Manier, BA
A recent study found that rimegepant, an orally administered calcitonin gene-related peptide receptor antagonist, is safe and well-tolerated for up to 52 weeks in individuals with migraine, with no signs of...
01/09/2015
Treatment
Treatment
05/05/2011
Patients with large-vessel giant cell arteritis may see disease improvement when treated early with steroid-sparing agents, recent research reveals.
05/05/2011
Treatment
Treatment
05/05/2011
During a patient-profiling, data-driven study, researchers reveal 5 phenotypes associated with patients with rheumatoid arthritis.
05/05/2011
Treatment
Treatment
04/07/2011
Patients with early systemic sclerosis-associated lung disease experienced stabilized forced vital capacity with tocilizumab, researchers report.
04/07/2011
Treatment
Treatment
04/07/2011
Researchers find helpful clinical interventions associated with managing fatigue in patients with systemic sclerosis.
04/07/2011
Treatment
Treatment
03/25/2011
Patients with giant cell arteritis see long-term effects after 1 year of treatment with tocilizumab
03/25/2011
Drug Therapy
Drug Therapy
03/24/2011
According to a systematic review, there are varying recommendations guiding the use of methotrexate in patients with rheumatoid arthritis.
03/24/2011
Treatment
Treatment
12/01/2010
In this “Test Your Knowledge” series, Edward Shahady, MD, asks you to choose the most appropriate treatment approach for a middle-aged Black man with prediabetes.
12/01/2010